Ratings by Barclays (Jack Meehan)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/16/2024 | Laboratory Corporation of America | LH | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/30/2023 | Pinduoduo Inc. | PDD | Maintain | Overweight (N/A) |
|
Details | ||
| 5/31/2023 | Pinduoduo Inc. | PDD | Maintain | Overweight (N/A) |
|
Details | ||
| 3/29/2023 | Pinduoduo Inc. | PDD | Maintain | Overweight (N/A) |
|
Details | ||
| 11/30/2022 | Pinduoduo Inc. | PDD | Maintain | Overweight (N/A) |
|
Details | ||
| 10/27/2022 | Pinduoduo Inc. | PDD | Upgrade | Overweight (Equalweight) |
47.53 (124.14) |
161.18% | Details | |
| 6/1/2022 | Pinduoduo Inc. | PDD | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/19/2020 | Pinduoduo Inc. | PDD | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/20/2020 | Pinduoduo Inc. | PDD | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/24/2020 | Pinduoduo Inc. | PDD | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/17/2020 | InMode Ltd. | INMD | Maintain | Overweight (N/A) |
|
Details | ||
| 5/27/2020 | Pinduoduo Inc. | PDD | Downgrade | Equalweight (Overweight) |
64.89 (124.14) |
91.31% | Details | |
| 3/26/2020 | Mettler-Toledo | MTD | Upgrade | Equalweight (Underweight) |
645.53 (1199.46) |
85.81% | Details | |
| 3/26/2020 | Bruker | BRKR | Upgrade | Overweight (Equalweight) |
34.50 (78.05) |
126.23% | Details | |
| 3/2/2020 | PPD Inc. | PPD | New Coverage | Overweight (N/A) |
35.18 (47.30) |
34.45% | Details | |
| 2/19/2020 | InMode Ltd. | INMD | Maintain | Overweight (N/A) |
|
Details | ||
| 2/5/2020 | Waters Corp. | WAT | Maintain | Underweight (N/A) |
|
Details | ||
| 1/7/2020 | Quest Diagnostics | DGX | Downgrade | Equalweight (Overweight) |
105.11 (130.09) |
23.77% | Details | |
| 11/6/2019 | InMode Ltd. | INMD | Maintain | Overweight (N/A) |
|
Details | ||
| 11/6/2019 | Avantor Inc. | AVTR | Maintain | Overweight (N/A) |
|
Details | ||
| 11/5/2019 | Myriad Genetics | MYGN | Maintain | Underweight (N/A) |
|
Details | ||
| 10/31/2019 | Quidel Corp. | QDEL | Maintain | Overweight (N/A) |
|
Details | ||
| 10/30/2019 | Waters Corp. | WAT | Maintain | Underweight (N/A) |
|
Details | ||
| 10/9/2019 | Waters Corp. | WAT | Downgrade | Underweight (Equalweight) |
223.48 (299.23) |
33.9% | Details | |
| 10/9/2019 | Mettler-Toledo | MTD | Maintain | Underweight (N/A) |
|
Details | ||
| 10/9/2019 | Agilent | A | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/8/2019 | Qiagen NV | QGEN | Downgrade | Equalweight (Overweight) |
32.06 (41.22) |
28.57% | Details | |
| 10/1/2019 | Bruker | BRKR | Maintain | Equalweight (N/A) |
|
Details | ||
| 9/3/2019 | InMode Ltd. | INMD | New Coverage | Overweight (N/A) |
19.90 (17.14) |
-13.87% | Details | |
| 8/14/2019 | Myriad Genetics | MYGN | Downgrade | Underweight (Equalweight) |
44.55 (18.49) |
-58.5% | Details | |
| 8/2/2019 | Bio-Rad Labs | BIO | Maintain | Overweight (N/A) |
|
Details | ||
| 8/1/2019 | Myriad Genetics | MYGN | Upgrade | Equalweight (Underweight) |
29.14 (44.55) |
52.88% | Details | |
| 8/1/2019 | Hologic | HOLX | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/30/2019 | Genomic Health Inc. | GHDX | Upgrade | Equalweight (Underweight) |
68.66 (63.44) |
-7.6% | Details | |
| 7/15/2019 | Mettler-Toledo | MTD | Downgrade | Underweight (Equalweight) |
854.07 (1199.46) |
40.44% | Details | |
| 7/15/2019 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 7/15/2019 | Laboratory Corporation of America | LH | Maintain | Overweight (N/A) |
|
Details | ||
| 7/15/2019 | IQVIA Holdings | IQV | Maintain | Overweight (N/A) |
|
Details | ||
| 7/15/2019 | Avantor Inc. | AVTR | Maintain | Overweight (N/A) |
|
Details | ||
| 7/15/2019 | Agilent | A | Downgrade | Equalweight (Overweight) |
71.74 (133.91) |
86.66% | Details | |
| 7/12/2019 | Illumina | ILMN | Maintain | Overweight (N/A) |
|
Details | ||
| 6/14/2019 | Myriad Genetics | MYGN | Maintain | Underweight (N/A) |
|
Details | ||
| 6/11/2019 | Avantor Inc. | AVTR | New Coverage | Overweight (N/A) |
17.20 (24.41) |
41.92% | Details | |
| 5/1/2019 | Laboratory Corporation of America | LH | Maintain | Overweight (N/A) |
|
Details | ||
| 4/24/2019 | Waters Corp. | WAT | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/18/2019 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 3/18/2019 | Quidel Corp. | QDEl | Maintain | Overweight (N/A) |
|
Details | ||
| 3/18/2019 | Laboratory Corporation of America | LH | Maintain | Overweight (N/A) |
|
Details | ||
| 3/18/2019 | Charles River Labs | CRL | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/5/2019 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 3/1/2019 | Bio-Rad Labs | BIO | Maintain | Overweight (N/A) |
|
Details | ||
| 2/14/2019 | Quidel Corp. | QDEL | Maintain | Overweight (N/A) |
|
Details | ||
| 1/7/2019 | Myriad Genetics | MYGN | Maintain | Overweight (N/A) |
|
Details | ||
| 1/3/2019 | Bio-Rad Labs | BIO | Upgrade | Overweight (Equalweight) |
232.22 (280.13) |
20.63% | Details | |
| 12/10/2018 | Quidel Corp. | QDEL | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/3/2018 | Laboratory Corporation of America | LH | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/8/2018 | Charles River Labs | CRL | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/7/2018 | Myriad Genetics | MYGN | Maintain | Underweight (N/A) |
|
Details | ||
| 11/7/2018 | Genomic Health Inc. | GHDX | Maintain | Underweight (N/A) |
|
Details | ||
| 11/2/2018 | Bio-Rad Labs | BIO | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/25/2018 | Laboratory Corporation of America | LH | Maintain | Overweight (N/A) |
|
Details | ||
| 10/24/2018 | Waters Corp. | WAT | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/24/2018 | Quest Diagnostics | DGX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/24/2018 | Illumina | ILMN | Maintain | Overweight (N/A) |
|
Details | ||
| 10/23/2018 | IQVIA Holdings | IQV | Maintain | Overweight (N/A) |
|
Details | ||
| 9/24/2018 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 9/11/2018 | Myriad Genetics | MYGN | Maintain | Underweight (N/A) |
|
Details | ||
| 9/5/2018 | Quidel Corp. | QDEL | Maintain | Overweight (N/A) |
|
Details | ||
| 9/5/2018 | Qiagen NV | QGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 9/5/2018 | PerkinElmer | PKI | Upgrade | Equalweight (Underweight) |
92.43 (115.24) |
24.68% | Details | |
| 9/5/2018 | Myriad Genetics | MYGN | Downgrade | Underweight (Equalweight) |
49.79 (29.14) |
-41.47% | Details | |
| 9/5/2018 | Hologic | HOLX | Downgrade | Equalweight (Overweight) |
39.76 (76.22) |
91.7% | Details | |
| 9/5/2018 | Bio-Rad Labs | BIO | New Coverage | Equalweight (N/A) |
325.30 (232.22) |
-28.61% | Details | |
| 8/22/2018 | Myriad Genetics | MYGN | Maintain | Equalweight (N/A) |
|
Details |
